List of Tables
Table 1. RNA Based Therapeutics Market Trends
Table 2. RNA Based Therapeutics Market Drivers & Opportunity
Table 3. RNA Based Therapeutics Market Challenges
Table 4. RNA Based Therapeutics Market Restraints
Table 5. Global RNA Based Therapeutics Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global RNA Based Therapeutics Revenue Market Share by Company (2019-2024)
Table 7. Key Companies RNA Based Therapeutics Manufacturing Base Distribution and Headquarters
Table 8. Key Companies RNA Based Therapeutics Product Type
Table 9. Key Companies Time to Begin Mass Production of RNA Based Therapeutics
Table 10. Global RNA Based Therapeutics Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA Based Therapeutics as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global RNA Based Therapeutics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global RNA Based Therapeutics Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global RNA Based Therapeutics Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global RNA Based Therapeutics Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global RNA Based Therapeutics Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global RNA Based Therapeutics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global RNA Based Therapeutics Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global RNA Based Therapeutics Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global RNA Based Therapeutics Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global RNA Based Therapeutics Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global RNA Based Therapeutics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global RNA Based Therapeutics Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global RNA Based Therapeutics Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global RNA Based Therapeutics Sales Value by Region (2019-2024) & (%)
Table 27. Global RNA Based Therapeutics Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions RNA Based Therapeutics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions RNA Based Therapeutics Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions RNA Based Therapeutics Sales Value, (2025-2030) & (US$ Million)
Table 31. ISIS pharmaceuticals (USA) Basic Information List
Table 32. ISIS pharmaceuticals (USA) Description and Business Overview
Table 33. ISIS pharmaceuticals (USA) RNA Based Therapeutics Products, Services and Solutions
Table 34. Revenue (US$ Million) in RNA Based Therapeutics Business of ISIS pharmaceuticals (USA) (2019-2024)
Table 35. ISIS pharmaceuticals (USA) Recent Developments
Table 36. Quark Pharmaceuticals (USA) Basic Information List
Table 37. Quark Pharmaceuticals (USA) Description and Business Overview
Table 38. Quark Pharmaceuticals (USA) RNA Based Therapeutics Products, Services and Solutions
Table 39. Revenue (US$ Million) in RNA Based Therapeutics Business of Quark Pharmaceuticals (USA) (2019-2024)
Table 40. Quark Pharmaceuticals (USA) Recent Developments
Table 41. Alnylam Pharmaceuticals (USA) Basic Information List
Table 42. Alnylam Pharmaceuticals (USA) Description and Business Overview
Table 43. Alnylam Pharmaceuticals (USA) RNA Based Therapeutics Products, Services and Solutions
Table 44. Revenue (US$ Million) in RNA Based Therapeutics Business of Alnylam Pharmaceuticals (USA) (2019-2024)
Table 45. Alnylam Pharmaceuticals (USA) Recent Developments
Table 46. Dicerna Pharmaceuticals (USA) Basic Information List
Table 47. Dicerna Pharmaceuticals (USA) Description and Business Overview
Table 48. Dicerna Pharmaceuticals (USA) RNA Based Therapeutics Products, Services and Solutions
Table 49. Revenue (US$ Million) in RNA Based Therapeutics Business of Dicerna Pharmaceuticals (USA) (2019-2024)
Table 50. Dicerna Pharmaceuticals (USA) Recent Developments
Table 51. Tekmira Pharmaceuticals Corp. (Canada) Basic Information List
Table 52. Tekmira Pharmaceuticals Corp. (Canada) Description and Business Overview
Table 53. Tekmira Pharmaceuticals Corp. (Canada) RNA Based Therapeutics Products, Services and Solutions
Table 54. Revenue (US$ Million) in RNA Based Therapeutics Business of Tekmira Pharmaceuticals Corp. (Canada) (2019-2024)
Table 55. Tekmira Pharmaceuticals Corp. (Canada) Recent Developments
Table 56. Benitec Biopharma Limited (Australia) Basic Information List
Table 57. Benitec Biopharma Limited (Australia) Description and Business Overview
Table 58. Benitec Biopharma Limited (Australia) RNA Based Therapeutics Products, Services and Solutions
Table 59. Revenue (US$ Million) in RNA Based Therapeutics Business of Benitec Biopharma Limited (Australia) (2019-2024)
Table 60. Benitec Biopharma Limited (Australia) Recent Developments
Table 61. Genzyme Corporation (USA) Basic Information List
Table 62. Genzyme Corporation (USA) Description and Business Overview
Table 63. Genzyme Corporation (USA) RNA Based Therapeutics Products, Services and Solutions
Table 64. Revenue (US$ Million) in RNA Based Therapeutics Business of Genzyme Corporation (USA) (2019-2024)
Table 65. Genzyme Corporation (USA) Recent Developments
Table 66. Silence Therapeutics PLC (UK) Basic Information List
Table 67. Silence Therapeutics PLC (UK) Description and Business Overview
Table 68. Silence Therapeutics PLC (UK) RNA Based Therapeutics Products, Services and Solutions
Table 69. Revenue (US$ Million) in RNA Based Therapeutics Business of Silence Therapeutics PLC (UK) (2019-2024)
Table 70. Silence Therapeutics PLC (UK) Recent Developments
Table 71. Cenix BioScience GmbH (Germany) Basic Information List
Table 72. Cenix BioScience GmbH (Germany) Description and Business Overview
Table 73. Cenix BioScience GmbH (Germany) RNA Based Therapeutics Products, Services and Solutions
Table 74. Revenue (US$ Million) in RNA Based Therapeutics Business of Cenix BioScience GmbH (Germany) (2019-2024)
Table 75. Cenix BioScience GmbH (Germany) Recent Developments
Table 76. Key Raw Materials Lists
Table 77. Raw Materials Key Suppliers Lists
Table 78. RNA Based Therapeutics Downstream Customers
Table 79. RNA Based Therapeutics Distributors List
Table 80. Research Programs/Design for This Report
Table 81. Key Data Information from Secondary Sources
Table 82. Key Data Information from Primary Sources
Table 83. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. RNA Based Therapeutics Product Picture
Figure 2. Global RNA Based Therapeutics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global RNA Based Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 4. RNA Based Therapeutics Report Years Considered
Figure 5. Global RNA Based Therapeutics Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by RNA Based Therapeutics Revenue in 2023
Figure 7. RNA Based Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. qRT-PCR Picture
Figure 9. RNA Interference (RNAi) Technologies Picture
Figure 10. RNA Antisense Picture
Figure 11. Inhibition Picture
Figure 12. Microarrays Picture
Figure 13. Labeling Picture
Figure 14. Purification Picture
Figure 15. Global RNA Based Therapeutics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global RNA Based Therapeutics Sales Value Market Share by Type, 2023 & 2030
Figure 17. Product Picture of Cardiovascular
Figure 18. Product Picture of Kidney Diseases
Figure 19. Product Picture of Oncology
Figure 20. Product Picture of Infectious Diseases
Figure 21. Product Picture of Metabolic Disorders
Figure 22. Global RNA Based Therapeutics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 23. Global RNA Based Therapeutics Sales Value Market Share by Application, 2023 & 2030
Figure 24. North America RNA Based Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 25. North America RNA Based Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 26. Europe RNA Based Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 27. Europe RNA Based Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 28. Asia Pacific RNA Based Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 29. Asia Pacific RNA Based Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 30. South America RNA Based Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 31. South America RNA Based Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 32. Middle East & Africa RNA Based Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 33. Middle East & Africa RNA Based Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 34. Key Countries/Regions RNA Based Therapeutics Sales Value (%), (2019-2030)
Figure 35. United States RNA Based Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 36. United States RNA Based Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 37. United States RNA Based Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 38. Europe RNA Based Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 39. Europe RNA Based Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 40. Europe RNA Based Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 41. China RNA Based Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 42. China RNA Based Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 43. China RNA Based Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 44. Japan RNA Based Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 45. Japan RNA Based Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 46. Japan RNA Based Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 47. South Korea RNA Based Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 48. South Korea RNA Based Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 49. South Korea RNA Based Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 50. Southeast Asia RNA Based Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 51. Southeast Asia RNA Based Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 52. Southeast Asia RNA Based Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 53. India RNA Based Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 54. India RNA Based Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 55. India RNA Based Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 56. RNA Based Therapeutics Industrial Chain
Figure 57. RNA Based Therapeutics Manufacturing Cost Structure
Figure 58. Channels of Distribution (Direct Sales, and Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
